Market Research Logo

Pharmaceutical Contract Development and Manufacturing Market by Service (Pharmaceutical, Biologics, Active Pharma Ingredients, Tablet, Capsule, Parenteral, Oral Liquid), End User (Big Pharma, Small Pharma, Generic Pharma, CRO) - Global Forecast to 2024

Pharmaceutical Contract Development and Manufacturing Market by Service (Pharmaceutical, Biologics, Active Pharma Ingredients, Tablet, Capsule, Parenteral, Oral Liquid), End User (Big Pharma, Small Pharma, Generic Pharma, CRO) - Global Forecast to 2024

“The global pharmaceutical contract development and manufacturing market is projected to grow at a CAGR of 7.1%.”
The pharmaceutical contract development and manufacturing market is expected to reach USD 126.6 billion by 2024 from an estimated USD 90.0 billion in 2019, at a CAGR of 7.1%. The rising demand for generics, increasing investments in pharmaceutical R&D, and investments in advanced manufacturing technologies by CDMOs are the primary growth factors for this market. The increasing demand for biological therapies, growing focus on specialty medicines, growth in the nuclear medicines sector, and advancements in cell and gene therapies are expected to offer significant growth opportunities for players in this market. However, the introduction of serialization and changing trade policies between countries are major market challenges.

“The biologics manufacturing segment is expected to grow at the highest rate during the forecast period.”
On the basis of service, the pharmaceutical contract development and manufacturing market is segmented into pharmaceutical manufacturing, biologics manufacturing, and drug development services. The biologics manufacturing segment is projected to witness the highest growth in the pharmaceutical contract development and manufacturing market during the forecast period. Growth in this segment is largely driven by the growing generics market and the impending patent cliff in the pharmaceuticals industry, which have propelled interest toward biologics.

“The big pharma end user segment is expected to account for the largest market share in 2019.”
The big pharma end-user segment holds the largest share of the pharmaceutical contract development and manufacturing market. The emergence of new medicines and therapy forms, pricing pressure, pipeline challenges, and growing opportunities in emerging markets are factors contributing to the larger share of this segment.

“The Asia Pacific is likely to be the fastest-growing market for players operating in the pharmaceutical contract development and manufacturing market.”
Although Europe accounted for the largest share of the global pharmaceutical contract development and manufacturing market in 2018, the Asia Pacific is expected to witness the highest CAGR during the forecast period. The growth of its manufacturing sector, favorable government regulations, expansions by leading companies, increasing emphasis on off-patent drugs, and its highly skilled workforce are factors driving the growth of this regional segment.

A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1 (21%), Tier 2 (26%), and Tier 3 (53%)
By Designation: C-level (32%), Director-level (26%), and Others (42%)
By Region: North America (35%), Europe (30%), Asia Pacific (15%), Latin America (10%), and the Middle East & Africa (10%)

The prominent players in the pharmaceutical contract development and manufacturing market include Thermo Fisher Scientific (US), Catalent (US), Lonza Group Ltd (Switzerland), Recipharm AB (Sweden), Vetter Pharma International GMBH (Germany), FAMAR Health Care Services (Greece), AbbVie (US), Aenova Group (Germany), Consort Medical plc (UK), Almac Group (UK), and Siegfried Holding AG (Switzerland).

Research Coverage:
This report analyzes the market for various pharmaceutical contract development and manufacturing services and their adoption patterns. It aims at estimating the market size and future growth potential of the global pharmaceutical contract development and manufacturing market and its service, end user, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the service portfolios offered by the top players in the global pharmaceutical contract development and manufacturing market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global pharmaceutical contract development and manufacturing market
Market Development: Comprehensive information on the lucrative emerging regions
Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the global pharmaceutical contract development and manufacturing market
Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global pharmaceutical contract development and manufacturing market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH APPROACH
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION
    • DATA TRIANGULATION APPROACH
    • MARKET PLAYERS RANKING ANALYSIS
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING: MARKET OVERVIEW
    • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • REGIONAL MIX: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET (2019-2024)
    • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2019 VS. 2024
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • OPPORTUNITIES
      • CHALLENGES
      • TRENDS
  • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE
    • INTRODUCTION
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
    • PHARMACEUTICAL MANUFACTURING SERVICES
      • Table PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • PHARMACEUTICAL API MANUFACTURING SERVICES
        • Table PHARMACEUTICAL API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • PHARMACEUTICAL FDF MANUFACTURING SERVICES
        • Table PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
        • Table PARENTERAL/INJECTABLE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
        • Table TABLET MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
        • Table CAPSULE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
        • Table ORAL LIQUID MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
        • Table OTHER FORMULATION MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
    • DRUG DEVELOPMENT SERVICES
      • DRUG SUBSTANCE COMPLEXITY AND HIGH COSTS HAVE SUPPORTED THE OUTSOURCING OF DRUG DEVELOPMENT
        • Table DRUG DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
    • BIOLOGICS MANUFACTURING SERVICES
      • Table BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table BIOLOGICS MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • BIOLOGICS API MANUFACTURING SERVICES
        • Table BIOLOGICS API MANUFACTURING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • BIOLOGICS FDF MANUFACTURING SERVICES
        • Table BIOLOGICS FINISHED DOSAGE FORMULATIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER
    • INTRODUCTION
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • BIG PHARMA
      • EMERGENCE OF NEW MEDICINES AND THERAPY FORMS TO CONTRIBUTE TO THE GROWTH OF THIS MARKET
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR BIG PHARMA, BY COUNTRY, 2017-2024 (USD MILLION)
    • SMALL & MID-SIZE PHARMA
      • GROWING DEVELOPMENT OF BIOLOGIC DRUGS AND HIGH PRICING PRESSURE TO BOOST MARKET GROWTH
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR SMALL & MID-SIZE PHARMA, BY COUNTRY, 2017-2024 (USD MILLION)
    • GENERIC PHARMACEUTICAL COMPANIES
      • GROWING DEMAND FOR GENERICS TO SUPPORT MARKET GROWTH
        • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR GENERIC PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
    • OTHER END USERS
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY REGION
    • INTRODUCTION
      • Table PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY REGION, 2017-2024 (USD MILLION)
    • EUROPE
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • ITALY
        • Table ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • GERMANY
        • Table GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • FRANCE
        • Table FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • UK
        • Table UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table UK: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • SWITZERLAND
        • Table SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SWITZERLAND: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • SPAIN
        • Table SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table ROE: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • US
        • Table US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table US: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • CANADA
        • Table CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • INDIA
        • Table INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • CHINA
        • Table CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • JAPAN
        • Table JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • LATIN AMERICA
      • FAVORABLE COST STRUCTURE AND GOVERNMENT INVESTMENTS TO DRIVE PHARMACEUTICAL PRODUCTION IN LATAM
        • Table LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table LATIN AMERICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table LATIN AMERICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • GOVERNMENT SUPPORT TO BOOST LOCAL PRODUCTION IS EXPECTED TO OFFER GROWTH OPPORTUNITIES FOR THE CONTRACT MANUFACTURERS IN THE REGION
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY SERVICE, 2017-2024 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL FDF MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: BIOLOGICS MANUFACTURING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET RANKING
      • PHARMACEUTICAL CONTRACT DEVELOPMENT AND MANUFACTURING MARKET, BY KEY PLAYERS, 2018
    • COMPETITIVE LEADERSHIP MAPPING
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
    • COMPETITIVE SITUATION AND TRENDS
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES, 2016-2019
      • EXPANSIONS
        • Table EXPANSIONS, 2016-2019
      • ACQUISITIONS
        • Table ACQUISITIONS, 2016-2019
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2016-2019
  • COMPANY PROFILES
    • THERMO FISHER SCIENTIFIC INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • CATALENT, INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • LONZA GROUP LTD
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • RECIPHARM AB
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • VETTER PHARMA INTERNATIONAL GMBH
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • MNM VIEW
    • FAMAR HEALTH CARE SERVICES
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ABBVIE INC.
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • AENOVA GROUP
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • CONSORT MEDICAL PLC
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • MNM VIEW
    • ALMAC GROUP
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • SIEGFRIED HOLDING AG
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • EVONIK INDUSTRIES AG
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report